Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

March 30, 2017

Primary Completion Date

July 31, 2020

Study Completion Date

August 31, 2020

Conditions
Anticholinergics Toxicity
Interventions
DRUG

Physostigmine

Administration of physostigmine bolus followed by an infusion

DRUG

Lorazepam

Administration of lorazepam bolus followed by normal saline infusion

Trial Locations (1)

80045

University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora

All Listed Sponsors
collaborator

American Academy of Clinical Toxicology

OTHER

lead

University of Colorado, Denver

OTHER

NCT03090620 - Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome | Biotech Hunter | Biotech Hunter